{"symbol":"BSX","fiscalQuarter":"Q3-2012","reportDate":"2012-10-18","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q3-2012","postBrief":{"headline":"Boston Scientific Beats on EPS, Stock Down 3.9%","keyNumbers":[{"metric":"EPS","actual":"$0.16","expected":"N/A","surprise":"+46.79%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted strong performance in key product areas.","They expressed confidence in long-term growth despite current market challenges."],"summary":"Overall, management conveyed a sense of optimism about the company's direction. They emphasized the importance of innovation and market expansion."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Boston Scientific's earnings report shows a significant beat on EPS, which indicates better-than-expected profitability. However, the stock fell by 3.9%, likely due to investor concerns over the lack of revenue data and guidance. This reaction suggests that while the EPS surprise is positive, uncertainty about future performance may be weighing on investor sentiment.","metaDescription":"Boston Scientific (BSX) Q3 2012 earnings: EPS beat by 46.79%. Stock down 3.9%. Full breakdown."}}